Anti-Counterfeiting Pharma 2015

11th-12th March 2015

Marriott Regents Park, London, UK

Roadmapand patient safety

to brand protection

Prominent Speakers:-üSophie Molle ,IPM Private Sector – Senior Manager, World Customs OrganizationüRoger Pallavicini, Sales Director Europe, Jura JSP GmbHüAndrew Love, VP Capability Development Be4ward LtdüEdmond D'arvieu, Chief Security Officer, SanofiüEric Noehrenberg, Regional Market Access and Policy Lead, Shire Pharmaceuticalsü Dammika Peiris, Pharmacovigilance Manager and Head of Chugai Pharma Marketing Pharmacovigilance Office, Chugai Pharma UK Ltdü Sumit Munjal, Medical Director Lead, Global Medical Safety, Takeda PharmaceuticalsüAdesina Iluyemi, Executive Board member, NEPAD CouncilüMartin FitzGerald, Deputy Director General, GIRPüJanice Kite, Traceability Director Healthcare, GS1 Global OfficeüStephen Wilkins, Secretary, Child Safe Packaging GroupüPaul Abbott, Associate, Arnold & Porter (UK) LLPüStephen Truick, Internet Infrastructure Manager, MHRAüMark Davison, CEO, Blue Sphere Health LtdüStephen McIndoe, Vice President, Be4ward LtdüJean-Luc Lasne, International Business Development & Alliance Director, Adents Pharma

Media Partner

Premium Sponsor

Exhibitor

Associate Sponsor

Floor Plan

13 14 15 16

12 11 10 9

1

2

Refreshment Station

Conference Hall

4

3

Registration

6

7

8

Re

fre

sh

me

nt

Sta

tio

n

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

5

Identify the current market trends in anti-counterfeiting, brand ?protection and security packaging

Gain Sanofi's perspective on key strategies for combating ?anti-counterfeiting

Overcome the main issues of online pharmaceutical crime ?by learning from the presentation by MHRA.

Understand the parallel trade, counterfeit products and ?public health issues from Shire Pharmaceuticals.

Hear thought provoking case study about preventing poisoning ?through mobile technology by NEPAD Council.

Discover latest solutions of future proofing a secure supply chain that will improve ?your business model with The European Association of Pharmaceutical Full-line Wholesalers.

Examine the recent EU&US anti-counterfeiting legislation with Arnold & Porter (UK) ?LLP that will shape your future decisions.

Learn how to enable regulatory compliance, supply chain security and patient safety ?with GS1.

Develop your serialisation strategy by learning from the experts from Blue Sphere ?Health Ltd and Be4ward Ltd.

Take part in the panel and roundtable discussions to interact, discuss and debate the ?most crucial topics of anti-counterfeiting and brand protection in the industry.

Why Attend??

Anti-Counterfeiting experts?R&D ?Supply Chain and Track & Trace?Serialisation?Packaging Technologists?Regulatory Affairs, Intellectual Property and Trademarks?Innovation, Design and Development?Sales & Marketing?Brand Protection?

Who will be attending?

Day One: 11th March 2015

10:10 GS1 Standards: A tool for fighting counterfeiting?ØØ The latest in GS1 developmentsØ Enabling regulatory compliance, supply chain security and patient safety

Daily interaction is natural and unnoticed

Andrew Love, VP Capability Development, Be4ward Ltd

09:00 Chairman's opening remarks

09:10 Market trends: Anti-counterfeiting and Brand ProtectionØMarket trends in anti-counterfeiting, brand protection and security packagingØTrends in pharmaceutical packagingØTechnologies and innovationsØOutlook for pharma security packaging

Senior Representative, Smithers Pira

Ø Legal frameworkØ Counterfeit characteristicsØ Counterfeit trends and opportunities: supply chain, diversion, parallel trade and product theftsØ Anti-counterfeit strategy: Two pillars

09:40 Key strategies for combating anti-counterfeiting - a pharma industry engagement

Edmond D'arvieu, Chief Security Officer, Sanofi

Janice Kite, Traceability Director Healthcare, GS1 Global Office

11:10 How to make your serialization project a success ?

Mark Davison, CEO, Blue Sphere Health Ltd

11:30 Linking corporate strategy, brand protection and patient safetyØ Serialisation and authentication as business critical initiativesØ Process issues: what to look forØ Are you complying or competing? Achieving the elusive upside

08:30 Registration & refreshments

10:40 Coffee break & Speed Networking

Ø Choosing a relevant equipmentØ Pay attention to data exchangeØ The extra challenge of CMOsJean-Luc Lasne, International Business Development & Alliance Director, Adents Pharma

14:20 Panel Discussion: Is the pharmaceutical industry doing enough to tackle counterfeit pharma products?ØChallenges in the industryØSolutions that matterØPublic and Private Sectors acting together against drug counterfeit

Moderator: Andrew Love, VP Capability Development, Be4ward Ltd

Panelists:

?Mark Davison, CEO, Blue Sphere Health Ltd

?Adesina Iluyemi, Executive Board member, NEPAD Council

?Edmond D'arvieu, Chief Security Officer, Sanofi

?Senior Representative, Aegate

Roger Pallavicini, Sales Director Europe, Jura JSP GmbH14:00 Add authentication to your identification system

12:20 Developing your Serialisation StrategyØ What are the capabilities that need to be implemented in a company to meet the needs of serialisation?Ø How do you ensure that the requirements for serialisation are thoroughly understood and capabilities effectively designed?Ø How do you ensure effective engagement across your extended supply chain?Ø How do you go about developing your serialisation strategy?

Stephen McIndoe, Vice President Consulting, Be4ward Ltd

15:40 Panel Discussion: Is the pharmaceutical industry doing enough to tackle counterfeit pharma products?

12:50 Networking Lunch

Ø Share your views and provide an overview of your product/services to the audience12:00 Sponsor Spotlight Session

15:20 Networking Coffee

Ø

Ø Solutions that matter

Ø Public and Private Sectors acting together against drug counterfeit

Moderator: Andrew Love, VP Capability Development,Be4ward Ltd

Panelists:

• Stephen Wilkins, Secretary, Child Safe Packaging Group

• Sumit Munjal,Medical Director Lead,Global Medical Safety ,Takeda Pharmaceuticals

• Dammika Peiris ,Pharmacovigilance Manager and Head of Chug ai Pharma Marketing

Pharmacovigilance Office, Chugai Pharma UK Ltd

Challenges in the industry

17:10 Chairman's closing remarks

17:20 Networking drinks reception

Ø Share your views and provide an overview of your product/services to the audience

16:50 Sponsor Spotlight Session

16:20 Online Pharmaceutical CrimeØ The main issues - why is this still a problemØ The current picture - it's not all Doom and GloomØ The future - when is a Door not a Door?

Stephen Truick, Internet Infrastructure Manager, MHRA

Day Two : 12th March 2015

Andrew Love, VP Capability Development, Be4ward Ltd

09:00 Chairman's opening remarks

09:10 Parallel trade and counterfeit productsØParallel trade, counterfeiting and public healthØThe extent of parallel trade and exploitation of parallel trade by drug counterfeitersØImpact of EU Falsified Medicines Directive on parallel trade and counterfeitingØImportance of cross-sectoral collaboration (including parallel traders) to fight counterfeiting

Eric Noehrenberg, Regional Market Access and Policy Lead, Shire Pharmaceuticals

Ø Drug counterfeiting a public health problem in AfricaØ An international view of drug counterfeiting in AfricaØ Cases studies of how mobile technology us empowering consumers and regulators

10:00 Preventing poisoning- mobile technology to the rescue

Adesina Iluyemi, Executive Board member, NEPAD Council

Senior Representative, Yellow BP10:30 Presentation to be announced

Martin FitzGerald, Deputy Director General,The European Association of Pharmaceutical Full-lineWholesalers (GIRP)

11:20 Future proofing a secure supply chainØ Addressing the challenges of supply chain security through medicines verification systemsØ Strategies for improving medicines supplyØ Innovative partnerships between wholesalers and manufacturers in the area of services

08:30 Refreshments

10:50 Networking Coffee

Ø Share your views and provide an overview of your product/services to the audience09:40 Sponsor Spotlight Session

15:50 Round table discussion

Round table discussion with today's speakers and audience

14:00 EU & US anti-counterfeiting legislationØBorder measures in the EU: the legislative frameworkØThe international situation: where are we with ACTA / future regulation of IP enforcement globally?ØPractical measures for preventing import of counterfeit pharmaceuticals

16:30 Chair summary of the day and close of conference

Paul Abbott, Associate, Arnold & Porter (UK) LLP

11:50 Presentation to be announced

Stephen Wilkins, Secretary, Child Safe Packaging Group

Sophie Molle, IPM Private Sector – Senior Manager, World Customs Organization14:30 IPM- A WCO global initiative to fight against counterfeiting

12:40 Networking Lunch

15:20 Raising public awareness of the dangers of counterfeit medicines

15:00 Networking Coffee

Share your views and provide an overview of your product/services to the audience

12:20 Sponsor Spotlight Session

Delegate Pricing InformationBook by

25 Dec2014 30 Jan 2015 30 Jan 2015

(Save upto ) (Save upto ) Standard Price

1 Delegate £550+ Vat £750+ Vat £950 + Vat

3 Delegates £1100+ Vat £1500 + Vat £1900+ Vat

Book by Book after

£800 £400

Commercial Opportunities:-

Anti-Counterfeiting Pharma 2015

offers various opportunities for you

to promote and showcase your

organisation to the attendees.

If you are interested in learning

more about how we can work

together please contact

Sarika Sareen at

sarika@recunnect.com

Terms & Conditions:Payment TermsRecunnect Ltd. requires full payment of the amount to be made before the conference. We may refuse entry to a delegateor sponsor who have not paid in full.

Cancellation or Substitution PolicyOnce registered, these places are not transferable without the agreement of Recunnect Ltd. for which reasonable priornotice must be given.For any cancellations received in writing not less than eight (8) days prior to the event, we will provide you with a 90%credit to be used at another Recunnect Ltd. event which must occur within one year from the date of issuance of suchcredit. An administration fee of 10% of the registration fee will be retained by Recunnect Ltd. for all permittedcancellations. No credit will be issued for any cancellations occurring within seven (7) days (inclusive) of the event.

IndemnityRecunnect Ltd. reserves the right to make alterations to the event / executive briefing content, timing, speakers orprogram and venues. Where major or significant changes occur shortly before the conference date, Recunnect Ltd. willendeavor to take reasonable steps to notify the customers using the contact details supplied.The event may be postponed or cancelled due to unforeseen events beyond the control of Recunnect Ltd. In the eventthat Recunnect Ltd. cancels or postpones an event for any reason, the customer will receive a refund of the of theregistration fee paid. The refund will be made within 30 days from the date of cancellation of the conference.

FeeThe conference fee includes lunch, refreshments and conference papers provided on the day. This fee does not includetravel, hotel accommodation, transfers or insurance, (which we strongly recommend you obtain).

ContactOur preferred method of communication is by email and phone. Please ensure that you complete the registration form infull so that we can contact you.By signing up for this conference you agree to abide by our terms and conditions. Please refer to our website for our fullterms and conditions.http://www.recunnect.com/terms-and-conditions.html

Registration Checklist:-

üHave you checked if any other colleagues are attending?

üBooking early enough for maximum advantage?

üAre you availing our 3 for the price of 2 offer?üUse your account manager code to avail

£50 discount.

Ways to Book:-

üü Call +44 (0) 2071129183 üEmail: info@recunnect.com

http://www.recunnect.com/p-anti-registration.html